key: cord-0983702-oppl2qtc
authors: Stoto, M.; Schlageter, S.; Kraemer, J. A.
title: COVID-19 mortality in the United States: It's been two Americas from the start
date: 2022-02-24
journal: nan
DOI: 10.1101/2022.02.23.22271411
sha: 164a377ff2a36f392cce90b5483f44ff8ef3b19d
doc_id: 983702
cord_uid: oppl2qtc

During the summer of 2021, a narrative of "two Americas" emerged: one with high demand for the COVID-19 vaccine and the second with widespread vaccine hesitancy and opposition to masks and vaccines. We analyzed "excess mortality" rates (the difference between total deaths and what would have been expected based on earlier time periods) prepared by the CDC for the United States from January 3, 2020 to September 26, 2021. Between Jan. 3, 2020 and Sept. 26, 2021, there were 895,693 excess deaths associated with COVID-19, 26% more than reported as such. The proportion of deaths estimated by the excess mortality method that were reported as COVID-19 was highest in Northeast (92%) and lowest in the West (72%) and South (76%). Of the estimated deaths, 43% occurred between Oct. 4, 2020 and Feb. 27, 2021. Before May 31, 2020, approximately 56% of deaths were in the Northeast, where 17% of the population resides. Subsequently, 48% of deaths were in the South, which makes up 38% of the population. Since May 31, 2020, the South experienced COVID-19 mortality 26% higher than the national rate, whereas the Northeasts rate was 42% lower. If each region had the same mortality rate as the Northeast, more than 316,234 COVID-19 deaths between May 31, 2020 and Sept. 26, 2021 were "avoidable." More than half (63%) of the avoidable deaths occurred between May 31, 2020 and February, 2021, and more than half (60%) were in the South. Regional differences in COVID-19 mortality have been strong throughout the pandemic. The South has had higher mortality rates than the rest of the U.S. since May 31, 2020, and experienced 62% of the avoidable deaths. A comprehensive COVID-19 policy, including population-based restrictions as well as vaccines, is needed to control the pandemic.

During the summer of 2021, as vaccine uptake slowed, a narrative of "two Americas" 38 emerged: one with a high demand for the COVID-19 vaccine and the second with high vaccine 39 hesitancy, and later widespread opposition to mask and vaccine mandates. The second 40 America was mostly concentrated in Southern states and rural areas, especially in counties that 41 voted for Donald Trump. Through the summer, the numbers of cases, hospitalizations, and 42 deaths increased dramatically in the second America [1, 2] . This narrative shapes not only our 43 understanding of what happened, but also what should, or could, be done to control the 44 ongoing pandemic. 45 However, our analysis of how COVID-19 mortality evolved over time shows that stark 46 regional differences existed from the start of the pandemic, both in cases and deaths as well as 47 testing and vaccine uptake. To see this, we analyzed "excess mortality," the difference 48 between total deaths and what would have been expected based on earlier time periods. 49 Reported cases, hospitalizations, and deaths are known to substantially underestimate actual 50 infections and deaths by a variable fraction depending on testing availability, patient and 51 physician awareness and attitudes, hospital resources, and other factors [3, 4] . Since COVID-19 52 awareness and concern, as well as test availability and use, vary markedly throughout the U.S., 53 excess mortality estimates can help avoid potential bias due to systematic differences in 54 reporting between areas with high and low prevalence areas.

In order to identify when regional differences in the pandemic emerged, and their 58 temporal association with vaccine uptake, we analyzed the evolution of COVID-19 mortality 59 patterns. Our analysis is based on state-level weekly excess mortality calculations published by 60 CDC [5] . Estimates from other sources might be slightly different, but the differences are not so 61 great as to affect the overall conclusions. In order to avoid reporting lags that potentially vary 62 by region (especially during the summer of 2021 when some states experienced far greater 63 caseloads than others), we concluded the analysis on September 26, 2021.

We grouped the states into the four standard Census regions. Other ad hoc groupings 65 could exaggerate or minimize differences. The on-line appendix includes figures comparing the 66 per-capita weekly rates of excess mortality to demonstrate the similarity of patterns within 67 each region. This is especially true in the Northeast and South, but there is more internal 68 variation in the West, where California is somewhat of an outlier. Based on a preliminary . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 24, 2022. ; https://doi.org/10.1101/2022.02.23.22271411 doi: medRxiv preprint 69 analysis of the data, we designated five periods with substantially different patterns of excess 70 mortality.

Vaccine coverage rates were calculated by Eva Rest of Georgetown University based on 72 a data set compiled by Tiu and colleagues [6] .

Between Jan. 3, 2020 and Sept. 26, 2021, the excess mortality associated with COVID-19 76 in the U.S. totaled 895,693, a per capita rate of 270 per 100,000 population. During the same 77 period, 710,999 COVID-19 deaths were reported, amounting to 79% of the estimated excess 78 mortality. In other words, during this period the U.S. experienced 26% more COVID-19 deaths 79 than reported as such.

As can be seen in Figure 1 , over time there are clear differences among the regions, 81 especially between the Northeast and South. Figure 2 shows 43% of the excess deaths 82 occurred between Oct. 4, 2020 and Feb. 27, 2021. Before May 31, 2020 (period 1), 83 approximately 56% of deaths were in the Northeast; subsequently, 48% were in the South. Controlling for the different sizes of the regions and lengths of the periods, Table 1 93 displays excess mortality by region per 100,000 population per day. Before May 31, 2020, the 94 daily mortality rate in the Northeast (0.881 per 100,000) was 3.3 times the national rate while 95 the rate for the South (0.132 per 100,000) was 48% of the national rate. Subsequently, the 96 South experienced COVID-19 mortality 26% higher than the national rate, whereas the 97 Northeast's rate was 42% lower.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 24, 2022. 

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 24, 2022. ; https://doi.org/10.1101/2022.02.23.22271411 doi: medRxiv preprint Table 1 also shows that the ratio of estimated to reported COVID-19 deaths varies over 103 time and among the regions. The proportion is lowest in the West (71.8%) and South (76.2%). 104 The proportions were similar in all regions (approximately 82%) in Period 1, but vary markedly 105 afterwards, dropping to less than 60% in the West in some periods. The overall proportion is 106 highest in Northeast (92%), and is greater than 100% in the third and fourth period (109% and 107 121% respectively. This is probably because some people who died of another primary cause 108 had a positive COVID-19 test and were included in the reported counts [7], as called for by the 109 National Center for Health Statistics [8] .

Because the rates of excess mortality vary so markedly, one can calculate how many 111 deaths could have been avoided if each region had the same rates as the lowest region in each 112 time period. We assume that no deaths were avoidable in the first period, before much was 113 known about treating or preventing COVID-19. Subsequently, we counted as "avoidable" the 114 difference between the rates seen and those in the Northeast, which were the lowest in each 115 period. According to this calculation, 316,234 COVID-19 deaths between May 31, 2020 and 116 Sept. 26, 2021 were "avoidable." Figure 3 shows that more than half of the avoidable deaths 117 (62%) were in the South. More than half (63%) of the avoidable deaths occurred between May 118 31, 2020 and February, 2021, and an additional 36% between June 27 and Sept. 26, 2021. The theme of "two Americas" arose in the summer of 2021, regarding at first vaccine 125 refusal, and later opposition to vaccine and mask mandates and more generally, covid-126 denialism [9] . However, our analysis of excess mortality demonstrates that large disparities 127 have existed since the beginning of the pandemic in the U.S. The starkest contrast is between 128 the Northeast and South. As first noted by Woolf and colleagues [10] for 2020, the first wave of 129 the pandemic was highly concentrated in the Northeast, and particularly in the New York 130 metropolitan area. Since May 31, 2020, however, approximately 48% all excess deaths were in 131 the South, which makes up 38% of the population. The disparity was most apparent in the 132 summer of 2020 (May 31 -Oct. 3), when the daily excess mortality rates were 0.539 per 133 100,000 in the South, 0.369 per 100,000 nationally, and 0.111 per 100,000 in the Northeast. 134 Similarly, of the 316,234 avoidable COVID-19 deaths between May 31, 2020 and Sept. 26, 2021, 135 the majority (62%) were in the South.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 24, 2022. ; https://doi.org/10.1101/2022.02.23.22271411 doi: medRxiv preprint

As a sensitivity analysis, we estimated the numbers of deaths that could have been 137 avoided in Period 1 as one-half of the difference between the actual rates and those in the 138 West (which had the lowest excess mortality rate in that period). This increases the number of 139 avoidable deaths to 402,700 an increase of 86,466. With this assumption the proportion of 140 avoidable deaths in the South was still high, 56%. 141

The regional level of analysis is simple enough for disparities to be clearly apparent, but 142 masks more extreme disparities at the state and local level. A Washington Post analysis, for 143 instance, demonstrates a strong relationship between the proportion who voted for Donald 144 Trump in 2020 and COVID-19 mortality at the county-level [11] . A second analysis shows a 145 strong correlation at the state level between vaccine uptake and the Trump vote [11] . Thus, the 146 disparities in this analysis are likely underestimates of actual differences at finer levels of 147 geography.

Strong resistance to vaccine and mask mandates emerged during the summer of 2021, 149 especially in the South and in states with Republican governors [12, 13] . Consistent with this, 150 excess mortality in the summer of 2021 was correlated with vaccine uptake. As seen in Table 1 , 151 the Northeast had the lowest COVID-19 mortality rates and the highest vaccination coverage: 152 52% of the population was fully vaccinated on June 27, 2021 and 60% on September 26, 2021. 153 The South, at the other extreme, had the highest COVID-19 mortality rates and lowest vaccine 154 coverage (40% and 49% on the same dates.

Nationally, vaccines have already saved many lives [14] and boosters have the potential 156 to save many more [15] . However, our analysis suggests that major differences in COVID-19 157 mortality emerged in the summer of 2020, well before vaccines became available. Indeed, 63% 158 of the avoidable deaths occurred by the end of February, 2021, when the vaccine rollout was 159 just beginning. These avoidable deaths occurred before the Delta variant became dominant in 160 the United States, so Delta is not part of the explanation. Similarly, because the South has had 161 dramatically higher COVID-19 mortality than the Northeast (since June, 2020) during all seasons 162 of the year, weather is not a likely explanation. Northeasters may have carried some natural 163 immunity into the summer of 2020 [16], but by July, 2020, Anand and colleagues estimate 164 substantially higher seroprevalence rates in the South (37.9%) than in the Northeast (17.5%), so 165 natural immunity cannot explain the large differences starting in the summer of 2020 [17] . 166 Excess COVID-19 mortality in the South and other areas of the country, therefore, is likely to be 167 due at least in part to higher transmission resulting from differences in mask use, school 168 attendance, social distancing, and other behaviors.

Compared to estimates based on epidemiologic models, the excess mortality methods 170 and assumptions are simple and straightforward. While they cannot explain why some regions 171 had different mortality rates, excess mortality estimates can accurately document when and 172 where COVID-19 occurred. Although causal patterns are complex and difficult to ascertain, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 24, 2022. ; https://doi.org/10.1101/2022.02.23.22271411 doi: medRxiv preprint

implementation of and adherence to stay-at-home orders, mask use, and other 174 non-pharmaceutical interventions seem to be at least a partial explanation for the regional 175 differences in COVID-19 mortality

While improving vaccination coverage is clearly 178 important, our analysis demonstrates the potential impact of population-based restrictions as 179 well as vaccines

This 182 method provides objective estimates of COVID-19's impact on mortality that do not rely on test 183 availability, clinical decisions, and reporting processes that can lead to under -and over -184 counting. The ratio of estimated to reported COVID-19 deaths ranged from 121% (Northeast in 185 period 4) to 54% in the West and 56% in the South in the same period. An analysis of reported 186 COVID -19 deaths, therefore would have shown both fewer avoidable deaths and regional 187 disparities. The presence of reporting delays, which can be greater in some areas than others, 188 means that excess mortality estimates and differentials are not reliable for a period of weeks, 189 so excess mortality estimates are limited as real-time surveillance tools

COVID-19 clearly has played out 193 differently across the country over the nearly two years since it emerged. The analysis 194 therefore illustrates how the importance of going beyond cumulative case counts for the U.S. as 195 a whole that dominate the news cycle. Beyond the regional differences that are the focus of 196 this paper, there are substantial differences between rural and urban areas with states and 197 among socio-demographic groups

Here's how the most-and least-vaccinated states fared against the Delta 203 variant

National Academies of Sciences, Engineering, and Medicine. Evaluating Data Types: A 210 Guide for Decision Makers using Data to Understand the Extent and

Covid-19: One year on…

Characterizing the spatiotemporal heterogeneity of 219 the COVID-19 vaccination landscape

County-Level Estimates of Excess 223

Mortality Associated with COVID-19 in the United States. MedRxiv

Guidance for Certifying Deaths Due to Coronavirus Disease 227 2019 (COVID-19)

We're becoming two Americas: One healthy, one deliberately at risk. Washington 230 Post

Excess Deaths From COVID-19 and 234 Other Causes in the US

Bump P. What if, actually, vaccine advocates want people *not* to die? Washington Post 236

How Covid Became a Red-State Crisis. The New York Times

One nation, divisible -over vaccines

Vaccination Program at One Year: How Many Deaths and Hospitalizations Were Averted?. 248 The Commonwealth Fund

Responding to Omicron: 252 Aggressively Increasing Booster Vaccinations Now Could Prevent Many Hospitalizations 253 and Deaths. Commonwealth Fund

Antibodies to SARS-CoV-2 in 10 Sites in the United States

Prevalence of 259 SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a 260 cross-sectional study

Our World Data

A National Framework to Improve 265

Mortality, Morbidity, and Disparities Data for COVID-19 and Other Large-Scale Disasters